Tenderwize
Retour à la recherche

Open House Originale Agreement for Vericiguat

Techniker Krankenkasse·Hamburg, Germany·Deadline Sep 29, 2027 · 399 days left·Open·Supplies
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-24 - Vericiguat

46/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

46 / 100

Complexité

58 / 100

Facteurs de risque

Offers/contracts cannot be submitted via the portal; the notice says portal submission is technically not possible and...

Participation is limited to pharmaceutical undertakings with the required AMG status, seat location, authorisation, and...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until Sep 2027
  • Supply/rebate agreement for pharmaceutical products, specifically the active substance Vericiguat.
  • Open House arrangement with uniform contractual conditions for all eligible participants.
Afficher le résumé complet

This is a German Open House supply arrangement for Vericiguat (CPV 33600000 Pharmaceutical products) led by Techniker Krankenkasse, with hkk and HEK listed as participating buyers. It is not a classic competitive award procedure: all eligible pharmaceutical companies meeting the stated conditions may join during the contract period, with no exclusivity and no individual negotiations. The contract term is up to 24 months from 01.10.2025 to 30.09.2027, with automatic earlier end if patent/market exclusivity expires. No contract value is stated. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post, and the procurement documents are available electronically but were not analyzed in extracted text beyond the notice.

Risques

Offers/contracts cannot be submitted via the portal; the notice says portal submission is technically not possible and...

Participation is limited to pharmaceutical undertakings with the required AMG status, seat location, authorisation, and...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Applicant must be a pharmaceutical undertaking within the meaning of Section 4(18) AMG for the relevant medicinal product.
  • Applicant must have its seat in Germany, another EU Member State, or an EEA State.
  • Applicant must hold a valid marketing authorisation for the relevant medicinal product and/or otherwise be entitled to place it on the market in its own name.

Acheteur

Localisation

Hamburg, DEU

Identifiant

992-80116-93

Activité

Health

Lots (1)

LOT-0001

Open House Originale Agreement for Vericiguat

Open House supply arrangement for the active substance Vericiguat. The notice states that all suitable pharmaceutical companies may conclude a rebate agreement under Section 130c(1) SGB V. No exclusivity, no individual negotiations, and uniform conditions apply. The lot is nationwide in Germany.

SuppliesEU fundedElectronic submission

Localisation

DE600, Germany

Durée

Sep 2025 - Sep 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Sep 29, 2027

Détails de la procédure

Date de publication
18 Aug 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
540042-2025

Documents (1)

Document de consultation 1

Appels d'offres similaires

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3